Colorectal cancer chemotherapy regimens

FOLFIRI regimen is a combination of irinotecan and

fluorouracil. FOLFIRI regimen

can inhibit topoisomerase I and induce DNA single-strand breaks,

thereby inhibiting tumor growth

When selecting chemotherapy regimen, it is necessary to accurately evaluate the specific conditions of patients, such as age, physical condition, tumor characteristics, etc., so as to cooperate with doctors to formulate the most suitable chemotherapy regimen.